A brief profile of the members is presented below.

SRINIVASAN SESHAN

Srinivasan, also called Srini, is a co-founder of Eywa Pharma. He is currently the CEO of Eywa Pharma Inc., USA and member of the Board of Directors of Zista Pharma Limited, UK and Eywa Pharma Inc., USA.

He brings a business experience of 30 years in various roles including Managing Director and CEO of Matrix Laboratories, the Head of Global Emerging Markets for Mylan Inc., and as Managing Director of SVL Ltd, holding company for the industrial businesses of Shriram Group, Chennai.

He played a key role in the rapid growth achieved by Matrix, organically as well as through M&As. Matrix was valued at over USD 1 billion during the acquisition by Mylan in 2006.



VINCE SUNEJA

Vince is currently the Senior Vice President, Commercial Operations for USA and member of the Board of Directors of Eywa Pharma Inc., USA. He is also the global general counsel for the company.

Prior to Eywa, he was the CEO and Co-Founder of TwoFour Insight Group, LLC responsible for the financial management, operational oversight and strategic direction of the Company’s operations. Before starting TwoFour Insight Group, he worked with Mylan in senior leadership positions in areas of governmental affairs, policy, legal and regulatory. Prior to this, he was the First Secretary, Market Access and Compliance Attaché at the US Embassy in New Delhi, India.

Vince earned his Masters in Business Administration from the University of Pittsburgh’s Katz School of Business, Masters of Law in Global Health Law and a World Trade Organization Certificate from Georgetown University Law’s Institute of International Economic Law Center, and a Juris Doctor from Ohio Northern University, Petit College of Law.



KAVIT TYAGI

Kavit is currently the Senior Vice President, Business Development & Global API Sourcing and member of the Board of Directors of Eywa Pharma Inc., USA.

He has over 18 years of diversified global experience in finished dosage formulation and Active Pharmaceutical Ingredients. Prior to joining Eywa, Kavit was associated with Kyowa Hakko USA Inc as Sr. Vice President – Marketing, Strategy and Product Portfolio – Biopharmaceuticals & Amino Acid. Prior to Kyowa, Kavit was the Head – API Sales & Marketing and Product Portfolio (API) of Mylan Laboratories for North America.

Kavit received his Bachelor of Pharmacy from Nagpur University in India and his Masters in International Business Management from IMT Gaziabad, India.



PRASAD UPPALAPATI

Prasad is currently the Senior Vice President and Head ,Cranbury manufacturing site, NJ, USA for Eywa Pharma Inc., USA.

He has over 30 years of experience in varied functions such as production, formulation development, scale up and technology transfer, validation and process optimization, contract manufacturing , project conceptualization and justification and management of pharmaceutical operations. He has commissioned manufacturing facilities and has successfully led his team in achieving the installed capacity utilization within one year of commercialization of the plant. He has successfully faced multiple audits by various regulatory agencies including US FDA, MHRA UK and various other agencies.

Prior to Eywa, Prasad has worked for companies like Lupin Pharmaceuticals Inc., Novel Laboratories Inc., Ranbaxy Pharmaceuticals Inc. and has handled various dosage forms including Oral Solids, Oral Liquids, Topical solutions, Topical Ointments, Creams and Nasal sprays.

Prasad earned his MS in Pharmaceutical Sciences from Nagpur University in India.



PAUL DAVIS

Paul is currently the Vice President, Sales & Marketing for Eywa Pharma Inc., USA.

He started his career with UDL and rose to become Director of Sales with Mylan Laboratories Inc. He was also associated with McKesson Corporation as VP – Sales and National Accounts and was instrumental in expanding sales to institutional and Long-Term Care (LTC) markets as well as revamped the relationships with key partners.

Paul Davis has done his MBA, Marketing - University of Phoenix - Phoenix, Arizona and BS, Political Science and Sociology - Houston Baptist University, Houston, He has extensive experience in the Pharmaceutical industry spanning over 26 years.



KEITH GIUNTA

Keith is currently the Senior Director, Regulatory Affairs, US for Eywa Pharma Inc., USA.

Prior to joining Eywa, he was Director, Regulatory Affairs with Mylan Pharmaceuticals, Inc. and has extensive experience in the preparation and execution of regulatory submissions to ensure high quality with an overall objective to receive approval within the shortest time frame. Keith was also Director, Dosage Outsourcing & Formulation Project Management and Director, Regulatory Affairs in Matrix Laboratories, Inc. prior to joining Mylan.

Keith received his B.S. Biochemistry and B.S. Business Management from Virginia Tech, Virginia.